We might need an update to first-line treatment for type 2 diabetes, according to some experts.
In Australia metformin is the first-line treatment, with drugs called SGLT2 inhibitors considered a second-line approach if needed.
They work by increasing glucose excretion in the urine.
In the United States it’s common to use them as first-line treatment alongside metformin. Is that the right approach?
Guest/s
- Dr Ted Wu, endocrinologist and director of the diabetes centre at the Royal Prince Alfred Hospital in Sydney
Health Report - Separate stories podcast